.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Treeworks is stocked at 218 licensed dispensaries across Massachusetts, New Jersey, and Connecticut, 173 of them in Massachusetts, with the deepest coverage in Boston, Northampton, Fall River, Pittsfield, and Worcester. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Treeworks concentrated 38.28% of August 2026 sales in Tincture & Sublingual, where year-over-year growth reached 9.95% but month-over-month slipped 3.33%, while Vapor Pens held 26.01% share with 43.27% YoY growth and a 2.74% MoM decline. Edible contributed 20.88% share with 7.07% YoY growth and a marginal 0.11% MoM dip, as Topical at 8.78% share grew 9.79% YoY but fell 0.79% MoM; Concentrates remained the smallest at 6.06% share with 63.11% YoY growth offset by a 23.75% MoM contraction. With average price up 1.85% year over year to $41.75 and the brand ranked 1 in Tincture & Sublingual in New Jersey, the pattern indicates a portfolio anchored by a leading tincture position while faster-growing inhalables and concentrates add volatility on a monthly basis.
The divergence between double-digit YoY gains in Vapor Pens (43.27%) and Concentrates (63.11%) versus their MoM pullbacks of 2.74% and 23.75% implies Treeworks is extending reach into higher-velocity segments but encountering near-term replenishment and promo timing effects; meanwhile, the 9.95% YoY lift and 3.33% MoM dip in Tincture & Sublingual suggest a stable core that absorbs seasonal softness. Given Edible’s 20.88% share with 7.07% YoY growth and Topical’s 8.78% share with 9.79% YoY growth alongside modest MoM declines of 0.11% and 0.79%, the mix points to a defensive floor from wellness formats while inhalables drive incremental upside, implying a positioning that balances a category-leading tincture franchise with selective risk in cyclical, fast-moving segments.
Competitive Landscape
Treeworks sits at rank #2 in Massachusetts Tincture & Sublingual for August 2026, unchanged year over year from rank #2, a flat trajectory that contrasts with Good Feels Inc holding #1 while posting a -18.6% YoY sales decline and Levia remaining at #3 with 121.5% YoY sales growth. Stability at #2 across the last three months and on a year-over-year basis, paired with Chill Medicated rising from #6 to #4 on 204.0% YoY growth and Howl's slipping from #4 to #5 despite 10.9% YoY growth, implies that Treeworks’ consistent rank is being maintained against diverging competitor momentum rather than expanding share, signaling a need to defend against faster climbers below while capitalizing on softness above.
Notable Products
Treeworks’ August 2026 story opens with the steepest pullback: Party - THC-V/THC 2:1 Tropical Sour Berry Gummies 20-Pack fell 23.7% MoM to rank 6, while Sleep & Relief - CBD/CBN/THC 3:3:1 Mellow Mandarin Gummies 20-Pack slid 13.4% MoM at rank 8, signaling that value-sensitive and niche-cannabinoid edibles cooled even as overall category presence remained. Offsetting those declines, Relief - CBD/CBN/CBC/CBG/CBT/THC Soothing Strawberry Tincture jumped 20.5% MoM to rank 3 and CBD/THC 1:1 Extra Strength Canna Cream rose 14.8% MoM at rank 2, whereas the top seller Happy - CBD/CBG/THC 3:3:1 Tropical Passionfruit Hibiscus Hash Rosin Gummies 20-Pack inched up 4.2% MoM at rank 1 with $90,599, pointing to stability at the flagship while gains concentrate in non-edible formats. With two Tincture & Sublingual SKUs in the top ten and both posting either double-digit growth or a stable top-five rank, the mix indicates a shift toward therapeutic multi-cannabinoid use-cases over novelty edibles. Net pattern: Treeworks is consolidating leadership around a steady hero edible while reallocating momentum into tinctures and topicals, implying a commercial direction toward efficacy-led formulations rather than flavor-led experimentation.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
